Skip to main navigation Skip to search Skip to main content

A phase 111 multicenter randomized double-blind double-dummy parallel-group study to evaluate the efficacy and safety of fenebrutinib compared with ocrelizumab in adult patients with primary progressive multiple sclerosis

Upstate Medical University

Project: Research

Project Details

StatusActive
Effective start/end date07/13/21 → 07/12/26

Funding

  • Genentech Incorporated: $382,491.60